List of insiders holdings for Bellerophon Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time |
Shares Owned Directly Indirectly |
Total Shares Owned |
Filing |
| 1 | Linde North America Inc. 10% Owner |
2018-01-02 13:39:01 | 8,913,788 0 |
8,913,788 | Form 5 |
| 2 | VENROCK ASSOCIATES IV L P Venrock Healthcare Capital Partners III L.P. VHCP Co-Investment Holdings III LLC Shah Nimish P VHCP Management III LLC 10% Owner |
2020-02-14 16:05:49 | 3,553,583 0 |
3,553,583 | Form 13G |
| 3 | VENROCK ASSOCIATES IV L P VENROCK ENTREPRENEURS FUND IV L P VEF Management IV LLC Koh Bong Y Venrock Healthcare Capital Partners II L.P. Venrock Management IV LLC Venrock Partners Management LLC Venrock Partners L.P. VHCP Co-Investment Holdings II LLC VHCP Management II LLC 10% Owner |
2020-02-14 16:05:49 | 3,553,583 0 |
3,553,583 | Form 13G |
| 4 | Puissance Capital Management LP Puissance Life Science Opportunities Fund VI Puissance Capital Fund (GP) LLC Wang Theodore T 10% Owner |
2023-10-17 21:05:12 | 1,211,262 0 |
1,211,262 | Form 13D |
| 5 | Puissance Life Science Opportunities Fund VI Puissance Capital Fund (GP) LLC Puissance Capital Management LP Puissance Capital Management (GP) LLC Wang Theodore T 10% Owner |
2023-10-17 21:05:12 | 1,211,262 0 |
1,211,262 | Form 13D |
| 6 | NELSEN ROBERT Director 10% Owner |
2015-02-23 21:47:59 | 0 965,660 |
965,660 | Form 4 |
| 7 | Edmonds Amy VP Clinical Operations & Admin |
2019-09-30 16:39:40 | 445,886 0 |
445,886 | Form 4 |
| 8 | Tenenbaum Fabian Chief Executive Officer |
2019-11-19 16:36:08 | 407,459 0 |
407,459 | Form 4 |
| 9 | Amin Naseem Director |
2023-06-09 16:12:24 | 291,865 0 |
291,865 | Form 4 |
| 10 | Tasse Daniel Director |
2018-06-25 16:33:08 | 182,604 0 |
182,604 | Form 4 |
| 11 | Peacock Jonathan M Director |
2021-04-02 16:10:16 | 157,033 0 |
157,033 | Form 4 |
| 12 | Agrawal Amit Chief Operating Officer |
2015-07-13 06:50:52 | 100,000 0 |
100,000 | Form 4 |
| 13 | Fernandes Peter See Remarks |
2023-06-09 16:12:06 | 100,000 0 |
100,000 | Form 4 |
| 14 | Luehring Jens Director |
2018-06-25 16:32:39 | 95,213 0 |
95,213 | Form 4 |
| 15 | Quinn Deborah Chief Medical Officer |
2018-06-14 16:42:55 | 94,070 0 |
94,070 | Form 4 |
| 16 | Korner Assaf CFO |
2019-11-19 16:35:29 | 66,078 0 |
66,078 | Form 4 |
| 17 | Puissance Cross-Border Opportunities III LLC Puissance Capital Fund (GP) LLC Puissance Capital Management LP Puissance Capital Management (GP) LLC Wang Theodore T 10% Owner |
2020-05-22 06:46:16 | 53,327 0 |
53,327 | Form 13D |
| 18 | Dekker Martin See Remarks |
2023-06-09 16:11:29 | 50,000 0 |
50,000 | Form 4 |
| 19 | Kim Bobae VP Reg. Affairs & Quality |
2023-06-09 16:10:55 | 50,000 0 |
50,000 | Form 4 |
| 20 | Laccona Nicholas FINANCIAL OFFICER, (PFO & PAO) |
2023-02-14 16:46:13 | 50,000 0 |
50,000 | Form 4 |
| 21 | Shah Parag Suresh VP of Business Operations |
2023-06-09 16:11:50 | 50,000 0 |
50,000 | Form 4 |
| 22 | FARES Wassim Chief Medical Officer |
2020-09-14 16:04:17 | 30,000 0 |
30,000 | Form 4 |
| 23 | Huennekens R Scott Director |
2015-05-14 19:37:05 | 25,000 0 |
25,000 | Form 4 |
| 24 | Schoeps Megan Principal Financial Officer |
2017-12-13 16:36:29 | 22,248 0 |
22,248 | Form 4 |
| 25 | MEGLASSON MARTIN Chief Scientific Officer |
2015-05-22 07:32:54 | 19,098 0 |
19,098 | Form 4 |
| 26 | Teufel Crispin Director |
2023-06-09 16:10:09 | 14,607 0 |
14,607 | Form 4 |
| 27 | Cloyd Mary Ann Director |
2023-06-09 16:10:22 | 14,607 0 |
14,607 | Form 4 |
| 28 | Bruder Scott P Director |
2023-06-09 16:11:14 | 14,607 0 |
14,607 | Form 4 |
| 29 | Moura Andre V. Director |
2020-09-14 16:03:28 | 13,472 0 |
13,472 | Form 4 |
| 30 | Abrams David Treasurer |
2015-12-03 17:17:59 | 13,116 0 |
13,116 | Form 4 |
| 31 | Holt Matthew S. Director 10% Owner |
2016-06-21 18:21:04 | 10,000 0 |
10,000 | Form 4 |
| 32 | Weinstein Adam Director 10% Owner |
2017-09-26 16:53:15 | 10,000 0 |
10,000 | Form 4 |
| 33 | Heyrman Reinilde Chief Clinical Dev. Officer |
2015-03-16 17:06:27 | 9,909 0 |
9,909 | Form 4 |
| 34 | BENNETT MATTHEW Director |
2020-09-14 16:03:12 | 6,509 0 |
6,509 | Form 4 |
| 35 | Naidu Manesh Chief Business Officer |
2015-03-16 17:03:28 | 4,892 0 |
4,892 | Form 4 |
| 36 | ARCH VENTURE FUND VI LP ARCH VENTURE PARTNERS VI LP ARCH VENTURE PARTNERS VI LLC CRANDELL KEITH BYBEE CLINTON 10% Owner |
2017-01-04 13:45:36 | 0 0 |
0 | Form 13D |
| 37 | New Mountain Investments II LLC New Mountain Capital L.L.C. KLINSKY STEVEN B 10% Owner |
2022-02-14 10:45:44 | 0 0 |
0 | Form 13G |
| 38 | New Mountain Investments II LLC Allegheny New Mountain Partners L P New Mountain Affiliated Investors II LP New Mountain Capital L.L.C. New Mountain Partners II (AIV-A) L.P. New Mountain Partners II (AIV-B) L.P. New Mountain Partners II Special (AIV-A) LP KLINSKY STEVEN B 10% Owner |
2022-02-14 10:45:44 | 0 0 |
0 | Form 13G |